Quantum investing is finally getting the mainstream attention it deserves – and with it comes a lot of confusion. The Financial Times just published a piece on the “mind-bending complexities” of backing quantum technologies, and the title alone captures where many generalist investors are today.From a venture perspective, two things stand out. First, “quantum” is not one market but a stack of very different modalities, timelines and risk profiles – hardware (ion traps, neutral atoms, superconducting, photonics, spins), middleware, algorithms, and adjacent picks‑and‑shovels like cryogenics and control electronics. Second, public markets are already trying to price this future with very imperfect information, which creates volatility, hype cycles and, often, misalignment between capital and what the underlying science can realistically deliver in 5–10 years.For Europe, this complexity is both a challenge and an opportunity. A more patient, thesis‑driven approach – grounded in technical due diligence, realistic roadmaps and strategic industrial alignment – can become a competitive advantage versus momentum‑driven quantum bets elsewhere. The hard part isn’t finding “the next big quantum winner” but understanding which layer of the stack you are really underwriting, and over what horizon.
Link to the FT article:
https://www.ft.com/content/03346767-0e1b-4b68-8a56-ec81b3b31000
.png)
